USD 98.50 Million
3D Printed Drugs Market Size, Share, Growth Analysis, By Dosage Form(Tablet, Capsule, Multidrug Implant, Nanoparticles), By Technology Type(Inkjet Printing, Direct Write, Zip Dose, Thermal Inkjet Printing), By Application(Orthopedic, Neurology, Dental, Others), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35I2140 |
Region:
Global |
Published Date: September, 2024
Pages:
219
|Tables:
91
|Figures:
76
3D Printed Drugs Market Insights
Global 3D Printed Drugs Market size was valued at USD 84.9 Million in 2022 and is poised to grow from USD 98.50 Million in 2023 to USD 322.91 Million by 2031, at a CAGR of 16% during the forecast period (2024-2031).
The global 3D Printed Drugs market is a rapidly growing sector in the pharmaceutical industry. 3D printing technology is being increasingly used to create customized drug formulations, which can improve drug efficacy, reduce side effects, and provide personalized dosing. The 3D printing process involves creating a three-dimensional object by laying down successive layers of material, and in the case of drug manufacturing, this involves printing precise doses of drugs onto a substrate. North America dominates the market, followed by Europe and Asia Pacific. The growth of the market can be attributed to the increasing demand for personalized medicines, the ability of 3D printing to provide precise dosing and reduce side effects, and advancements in technology. The purpose of the 3D printed drugs market is to provide a new and innovative way of manufacturing drugs that can improve patient outcomes and reduce healthcare costs. The use of 3D printing technology in drug manufacturing can provide greater flexibility in drug design, reduce waste, and allow for the production of drugs on demand. The major driving factors for the growth of the 3D printed drugs market include increasing demand for personalized medicines, advancements in technology, the ability of 3D printing to provide precise dosing and reduce side effects, and the need to reduce healthcare costs. The major restraining factors for the growth of the 3D printed drugs market include the high cost of 3D printing technology and regulatory challenges associated with the approval of 3D printed drugs. The challenges in the 3D printed drugs market include the need for further research and development to ensure the safety and efficacy of 3D printed drugs, the need for standardization of 3D printing processes, and the potential for intellectual property disputes. The opportunities in the 3D printed drugs market include the development of new and innovative drug formulations, the expansion of the market to new regions, and the potential for 3D printing to transform drug delivery and personalized medicine. The use of 3D printing technology in drug manufacturing could also provide new revenue streams for pharmaceutical companies.
Market snapshot - 2024-2031
Global Market Size
Largest Segment
Zip Dose Technology
Fastest Growth
Inkjet Printing
Growth Rate
16% CAGR
Global 3D Printed Drugs Market, 2024-2031 ($ Bn)
Country Share for North America Region- 2024 (%)
To get more reports on the above market click here to Buy The Report
3D Printed Drugs Market Segmental Analysis
The global 3D printed drugs market is segmented based on dosage form, technology, application, and region. Based on technology, the market is segmented into Inkjet Printing, Direct Write, Zip Dose, Thermal Inkjet Printing, Fused Deposition Modelling, Powder Bed Printing, Stereolithography (SLA) and Semi Solid Extrusion (SSE). Based on application, the market is segmented into orthopedics, neurology, dental, and others. Based on dosage form, the market is segmented into Tablet, Capsule, Multidrug Implant, Nanoparticles, Solutions and Other Products. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and MEA.
Analysis by Technology
In the realm of 3D printing, Fused Deposition Modeling (FDM) now reigns supreme as the largest and quickest segment. FDM printers are comparatively inexpensive, easy to use, and able to create a large variety of items since they employ spools of molten filament that are deposited layer by layer. Although there are more precise technologies like as Stereolithography (SLA), FDM is faster and more accessible, which makes it a popular choice for designers, amateurs, and even small-scale production applications.
Analysis by Application
In 2023, the neurology section held a 49.84% market share, making it the dominant segment. The SPRITAM (levetiracetam) pills made by Aprecia Pharmaceutical were authorised by the FDA in August 2015 for the treatment of epilepsy. There isn't a single medicine that has been authorised and is sold. Pharmaceutical firms are now interested in investing in this market sector as a result of this clearance, which is driving the market's expansion.
However, orthopaedic treatments are difficult and complex, and new methods are required to address several identified problems and improve patient outcomes. Furthermore, problems often lead to prolonged patient suffering and loss of function, especially given the high likelihood of infection. Orthopaedic medications can therefore be used to prevent postoperative infections, which will fuel market expansion.
Analysis by Dosage
The most widely used and fastest-growing 3D printing method for medicine delivery is dosage segmentation in tablets and capsules. This is likely caused by many things, such as the fact that these dosage forms are well-known and simple to use, and that the printing settings allow for exact control over the drug's dosage and release profile.
Global 3D Printed Drugs Market Size By Technology 2024(%)
To get detailed analysis on other segments, Request For Free Sample Report
3D Printed Drugs Market Regional Insights
With a 37.23% share in the regional market in 2022, North America was in the lead. This significant portion is explained by a number of factors, including a rise in the prevalence of chronic illnesses, a strong domestic healthcare system, significant R&D spending, and the growing application of technical advancements in the North American area.
Because of the notable advancements made by China and Japan in the technical integration of 3D printed medicine techniques, the Asia Pacific area is predicted to expand at the highest rate. Additionally, growing nations like Australia and India are developing their clinical development frameworks, R&D, and healthcare infrastructure, which is positioning the Asia Pacific market for growth and profitable prospects over the course of the projected period.
Global 3D Printed Drugs Market Size By Geography, 2024-2031
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
3D Printed Drugs Market Dynamics
Drivers
- Increasing Demand for Personalized Medicines
The increasing demand for personalized medicines is a major driver of the global 3D Printed Drugs market. Personalized medicines are drugs that are tailored to the individual patient based on their genetics, environment, and lifestyle. These drugs offer several advantages over traditional drugs, including improved efficacy, reduced side effects, and increased patient compliance. 3D printing technology enables the creation of customized drug formulations with precise dosing and drug release characteristics, making it an ideal technology for the production of personalized medicines. With 3D printing, pharmaceutical companies can create drugs with unique geometries and formulations that cannot be achieved using traditional manufacturing methods. The demand for personalized medicines is increasing due to the rising prevalence of chronic diseases and the need for targeted drug delivery. Chronic diseases such as cancer, diabetes, and cardiovascular diseases require long-term treatment and personalized medicines can improve patient outcomes and quality of life. Additionally, targeted drug delivery can reduce the dose required, reducing side effects and improving patient compliance. The global 3D Printed Drugs market is expected to grow significantly in the coming years. With the increasing demand for personalized medicines and advancements in 3D printing technology, the global 3D Printed Drugs market is expected to continue to grow at a rapid pace.
- Advancements in Technology
Major advancements in technology is another major driver of the global 3D printed drugs market. Over the years, 3D printing technology has advanced significantly, enabling the creation of more complex and precise drug formulations. 3D printing technology has advanced to the point where it can create drugs with precise dosing and release characteristics. This level of precision enables pharmaceutical companies to create drugs that are tailored to individual patients, improving efficacy and reducing side effects. Advances in 3D printing technology have led to faster production times for 3D Printed Drugs. This has reduced the time required for drug development and manufacturing, allowing pharmaceutical companies to bring new drugs to market more quickly. 3D printing technology has expanded beyond the use of traditional plastics and metals to include a wide range of materials. This includes biocompatible materials that can be used for drug delivery, such as hydrogels and polymers.
Restraints
- High Cost of 3D Printing Technology
The initial investment required for 3D printing equipment, software, and materials can be significant, making it difficult for small and medium-sized pharmaceutical companies to adopt the technology. The cost per unit of 3D printed drugs can be higher than traditional drugs due to the high cost of materials and the time required for production. This can make 3D printed drugs less affordable for patients, reducing demand for the products. The regulatory framework for 3D printed drugs is still developing, and regulatory approval can be a lengthy and expensive process. This can further increase the cost of 3D printed drugs and limit their accessibility to patients.
- Regulatory Challenges
The development of 3D Printed Drugs is a relatively new technology, and regulatory authorities are still developing guidelines for the approval and regulation of these products. The lack of clear regulatory guidelines can make it difficult for pharmaceutical companies to develop and bring 3D Printed Drugs to market. The regulatory approval process for 3D Printed Drugs can be lengthy and expensive, which can further delay the availability of these products to patients. The lack of regulatory harmonization between different regions and countries can also make it difficult for companies to obtain approvals in different markets. There may be concerns about the quality and safety of 3D Printed Drugs. Regulatory challenges are a significant restraint for the global 3D Printed Drugs market, and it may slow down the adoption of this technology. It is expected that the regulatory challenges will be reduced, and the market for 3D Printed Drugs will continue to grow.
Request Free Customization of this report to help us to meet your business objectives.
3D Printed Drugs Market Competitive Landscape
The global 3D printed drugs market is very competitive in nature owing to various strategies including partnerships through geographical expansion, mergers and acquisitions, and strategic collaborations to expand their market presence. The business manufactures a variety of prescription drugs and vaccinations. The pharmaceutical industry finds, creates, and sells drugs to treat both acute and chronic illnesses. The vaccines industry offers vaccinations for individuals of all ages, from infants and adolescents to adults and senior citizens. Its product line includes HIV and respiratory medications. Respiratory, HIV, Specialty Products, and Classic and Established Products are all part of its pharmaceuticals division. Over 40 vaccinations for children, adolescents, adults, older adults, and travellers are included in the company's vaccine portfolio.
3D Printed Drugs Market Top Player’s Company Profiles
- Aprecia Pharmaceuticals, LLC (US)
- FabRx Ltd (UK)
- Cycle Pharmaceuticals (UK)
- GlaxoSmithKline plc (UK)
- AstraZeneca (UK/Sweden)
- Tvasta (India)
- Merck KGaA (Germany)
- Terumo Corporation (Japan)
- Extend Biosciences (US)
- BioDuro (US)
- Affinity Therapeutics (US)
- Osmotica Pharmaceuticals (US)
- Pfizer (US)
- Sanofi (France)
- 3D Systems (US)
- BASF (Germany)
- Teva Pharmaceuticals (Israel)
- Novartis (Switzerland)
- Roche (Switzerland)
- Catalent (US)
- Johnson & Johnson (US)
- Vertex Pharmaceuticals (US)
- Boehringer Ingelheim (Germany)
- Siemens Healthineers (Germany)
- Sandoz International (Germany)
- BioBots (US)
- Apium Additive Technologies (Germany)
- Boston Micro Fabrication (US)
3D Printed Drugs Market Recent Developments
-
In February 2024, 3D-Printed Microbes Produce Plant-Based Chemicals.
-
In February 2024, Cutting-edge technologies can transform India into a global pharma powerhouse.
-
In October 2023, Crucify launches GMP Pharma inks for on-site 3D printing of personalized medicines.
-
In September 2021, Merck announced that it had successfully 3D printed a tablet with multiple layers, which could release different drugs at different times, opening up new possibilities for personalized medicine.
3D Printed Drugs Key Market Trends
- Collaboration between pharmaceutical companies and 3D printing companies: The collaboration between pharmaceutical companies and 3D printing companies is becoming increasingly common in the global 3D Printed Drugs market. This collaboration is driving innovation in the industry and helping to bring new drugs and drug delivery devices to market faster. Pharmaceutical companies are partnering with 3D printing companies to develop new drugs and drug delivery devices. 3D printing technology allows for the production of complex drug formulations and personalized drugs with precise dosing and tailored formulations. collaboration between pharmaceutical companies and 3D printing companies is driving innovation in the global 3D Printed Drugs market. This collaboration is helping to bring new drugs and drug delivery devices to market faster, and is expected to continue driving growth in the industry in the coming years.
- Favorable government initiatives: Favorable government initiatives are playing a key role in the growth of the global 3D Printed Drugs market. Many governments around the world are introducing initiatives to support the development and adoption of 3D printing technology in healthcare. These initiatives are helping to create a supportive regulatory environment for the industry and driving growth in the market. favorable government initiatives are playing a key role in the growth of the global 3D Printed Drugs market. These initiatives are helping to create a supportive regulatory environment for the industry, driving innovation, and supporting the development of new drugs and drug delivery devices.
3D Printed Drugs Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyzes the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.
According to our analyses, The Global 3D Printed Drugs Market is expected to experience significant growth during the forecast period from 2022 to 2030. The global 3D Printed Drugs market refers to the market for pharmaceuticals that are manufactured using 3D printing technology. 3D printing, also known as additive manufacturing, involves the layer-by-layer creation of three-dimensional objects using a digital model. The technology has the potential to revolutionize the pharmaceutical industry by allowing for the customization of drugs to meet specific patient needs. The market for 3D printed drugs is expected to grow significantly in the coming years. The market is driven by the increasing demand for personalized medicine, as well as the benefits of 3D printing in drug development, such as the ability to produce complex drug formulations with precise dosing. The global 3D printed drugs market is a growing market with significant potential for growth in the coming years. The market is driven by the increasing demand for personalized medicine and the benefits of 3D printing technology in drug development.
| Report Metric | Details |
|---|---|
| Market size value in 2022 | USD 84.9 Million |
| Market size value in 2031 | USD 322.91 Million |
| Growth Rate | 16% |
| Base year | 2023 |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Million |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on 3D Printed Drugs Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on 3D Printed Drugs Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the 3D Printed Drugs Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the 3D Printed Drugs Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the 3D Printed Drugs Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the 3D Printed Drugs Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
